# The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

> **NCT06790082** · PHASE2 · RECRUITING · sponsor: **Aalborg University Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Pleural Mesothelioma
- Pleural Diseases
- Cancer
- FAPI
- Fibroblast Activation Protein Inhibitor

## Interventions

- **DRUG:** [68Ga]Ga-FAPI-46 PET/CT

## Key facts

- **NCT ID:** NCT06790082
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-29
- **Primary completion:** 2027-04-30
- **Final completion:** 2037-04-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06790082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06790082, "The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06790082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*